Arkolith/Insider Trading/ADIL/Form 4

Newman James W. Jr.

DirectorADIAL PHARMACEUTICALS, INC. (ADIL) · full profile →Form 4 · filed Nov 30, 2021
Net Buying
Open-Market Buys
$29K
Open-Market Sells
$0
Net Open-Market Flow
$29K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 26, 2021Buy(P)10K$2.85$29K34K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-21-062465) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML